STAT3 and colorectal carcinoma: IL-6 activates STAT3 to promote tumor initiation and growth67 and drives Fos-related antigen 1(FOSL1/ FRA1) deacetylation, endowing CRC cells with stem cell-like properties and enhancing their proliferation68.